An artificial intelligence-based gout management system reduced chronic kidney disease incident and improved target serum urate achievement
Han Qi(Qingdao University), Changgui Li(Guilin University of Aerospace Technology), Xinde Li(Qingdao University), Aichang Ji(Qingdao University), Yi Zhang(Fujian Medical University), Can Wang(Qingdao University), Jie Lü(Qingdao University), Lingling Cui(Qingdao University), Robert Terkeltaub(University of California San Diego), Nicola Dalbeth(University of Auckland), Mingshu Sun(Qingdao University), Ying Chen(Qingdao University), Zhen Liu(TCM-Intigrated Cancer Center of Southern Medical University), Fei Yan(Qingdao University), Lin Han(Qingdao University), Xiaopeng Ji(Qingdao University), Wenyan Sun(Qingdao University), Yuwei He(Qingdao University)
Cited by 1
Related Papers
GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes
|Annals of the Rheumatic Diseases|2016|173
Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease
|The American Journal of Medicine|2021|122
Parathyroid hormone–related peptide is a naturally occurring, protein kinase A–dependent angiogenesis inhibitor
|Nature Medicine|2002|102
Enolase-1 is a therapeutic target in endometrial carcinoma
|Oncotarget|2015|63